Parkinson Disease Clinical Trials in Phoenix, Arizona

4 studies are recruiting for parkinson disease in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

    The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

    Stage
    Not phased
    Ages
    Any age
    Site
    St. Joseph's Hospital & Medical Center, Phoenix, Arizona
    Locations
    20 in total
    Run by
    Boston Scientific Corporation

    See if you can join NCT03664609 on ClinicalTrials.gov

  2. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    Barrow Neurological Institute, Phoenix, Arizona
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT04477785 on ClinicalTrials.gov

  3. A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

    The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

    Stage
    Phase 2
    Ages
    45 to 75
    Site
    Mayo Clinic, Phoenix, Arizona
    Locations
    46 in total
    Run by
    AskBio Inc

    See if you can join NCT06285643 on ClinicalTrials.gov

  4. A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

    The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Barrow Neurological Institute, Phoenix, Arizona
    Locations
    27 in total
    Run by
    Impax Laboratories, LLC

    See if you can join NCT06765668 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.